메뉴 건너뛰기




Volumn 53, Issue 9, 2009, Pages 3894-3901

Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): Implications for dosing in MRSA pneumonia

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

EID: 70349085778     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01585-08     Document Type: Article
Times cited : (47)

References (43)
  • 1
    • 13644269309 scopus 로고    scopus 로고
    • Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
    • American Thoracic Society
    • American Thoracic Society. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416.
    • (2005) Am. J. Respir. Crit. Care Med. , vol.171 , pp. 388-416
  • 2
    • 0035178825 scopus 로고    scopus 로고
    • Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate
    • Boyle-Vavra, S., R. B. Carey, and R. S. Daum. 2001. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J. Antimicrob. Chemother. 48:617-625.
    • (2001) J. Antimicrob. Chemother. , vol.48 , pp. 617-625
    • Boyle-Vavra, S.1    Carey, R.B.2    Daum, R.S.3
  • 4
    • 33748677949 scopus 로고    scopus 로고
    • Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus
    • Chung, P., P. J. McNamara, J. J. Campion, and M. E. Evans. 2006. Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:2957-2965.
    • (2006) Antimicrob. Agents Chemother. , vol.50 , pp. 2957-2965
    • Chung, P.1    McNamara, P.J.2    Campion, J.J.3    Evans, M.E.4
  • 7
    • 0030782631 scopus 로고    scopus 로고
    • Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations
    • Dalla Costa, T., A. Nolting, K. Rand, and H. Derendorf. 1997. Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations. Int. J. Clin. Pharmacol. Ther. 35:426-433.
    • (1997) Int. J. Clin. Pharmacol. Ther. , vol.35 , pp. 426-433
    • Dalla Costa, T.1    Nolting, A.2    Rand, K.3    Derendorf, H.4
  • 9
    • 6944234949 scopus 로고    scopus 로고
    • Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling
    • Gumbo, T., A. Louie, M. R. Deziel, L. M. Parsons, M. Salfinger, and G. L. Drusano. 2004. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. J. Infect. Dis. 190:1642-1651.
    • (2004) J. Infect. Dis. , vol.190 , pp. 1642-1651
    • Gumbo, T.1    Louie, A.2    Deziel, M.R.3    Parsons, L.M.4    Salfinger, M.5    Drusano, G.L.6
  • 10
    • 33750285524 scopus 로고    scopus 로고
    • High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: Efficacy and toxicity
    • Hidayat, L. K., D. I. Hsu, R. Quist, K. A. Shriner, and A. Wong-Beringer. 2006. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch. Intern. Med. 166: 2138-2144.
    • (2006) Arch. Intern. Med. , vol.166 , pp. 2138-2144
    • Hidayat, L.K.1    Hsu, D.I.2    Quist, R.3    Shriner, K.A.4    Wong-Beringer, A.5
  • 11
    • 0031566835 scopus 로고    scopus 로고
    • Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
    • DOI 10.1016/S0140-6736(97)07324-8
    • Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673. (Pubitemid 28036828)
    • (1997) Lancet , vol.350 , Issue.9092 , pp. 1670-1673
    • Hiramatsu, K.1    Aritaka, N.2    Hanaki, H.3    Kawasaki, S.4    Hosoda, Y.5    Hori, S.6    Fukuchi, Y.7    Kobayashi, I.8
  • 12
    • 33750082642 scopus 로고    scopus 로고
    • Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: Specific evaluation of vancomycin pharmacokinetic indices
    • Jeffres, M. N., W. Isakow, J. A. Doherty, P. S. McKinnon, D. J. Ritchie, S. T. Micek, and M. H. Kollef. 2006. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 130:947-955.
    • (2006) Chest , vol.130 , pp. 947-955
    • Jeffres, M.N.1    Isakow, W.2    Doherty, J.A.3    McKinnon, P.S.4    Ritchie, D.J.5    Micek, S.T.6    Kollef, M.H.7
  • 13
    • 34547686271 scopus 로고    scopus 로고
    • A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
    • Jeffres, M. N., W. Isakow, J. A. Doherty, S. T. Micek, and M. H. Kollef. 2007. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin. Ther. 29:1107-1115.
    • (2007) Clin. Ther. , vol.29 , pp. 1107-1115
    • Jeffres, M.N.1    Isakow, W.2    Doherty, J.A.3    Micek, S.T.4    Kollef, M.H.5
  • 14
    • 0030838740 scopus 로고    scopus 로고
    • Bacterial interference caused by autoinducing peptide variants
    • DOI 10.1126/science.276.5321.2027
    • Ji, G., R. Beavis, and R. P. Novick. 1997. Bacterial interference caused by autoinducing peptide variants. Science 276:2027-2030. (Pubitemid 27443604)
    • (1997) Science , vol.276 , Issue.5321 , pp. 2027-2030
    • Ji, G.1    Beavis, R.2    Novick, R.P.3
  • 15
    • 29244477534 scopus 로고    scopus 로고
    • Microbiological features of vancomycin in the 21st century: Minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains
    • Jones, R. N. 2006. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin. Infect. Dis. 42(Suppl. 1):S13-S24.
    • (2006) Clin. Infect. Dis. , vol.42 , Issue.SUPPL. 1
    • Jones, R.N.1
  • 17
    • 34548507204 scopus 로고    scopus 로고
    • Limitations of vancomycin in the management of resistant staphylococcal infections
    • Kollef, M. H. 2007. Limitations of vancomycin in the management of resistant staphylococcal infections. Clin. Infect. Dis. 45(Suppl. 3):S191-S195.
    • (2007) Clin. Infect. Dis. , vol.45 , Issue.SUPPL. 3
    • Kollef, M.H.1
  • 18
    • 0043166886 scopus 로고    scopus 로고
    • Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus
    • Kuroda, M., H. Kuroda, T. Oshima, F. Takeuchi, H. Mori, and K. Hiramatsu. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821.
    • (2003) Mol. Microbiol. , vol.49 , pp. 807-821
    • Kuroda, M.1    Kuroda, H.2    Oshima, T.3    Takeuchi, F.4    Mori, H.5    Hiramatsu, K.6
  • 21
    • 9644255765 scopus 로고    scopus 로고
    • Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
    • LaPlante, K. L., and M. J. Rybak. 2004. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 48:4665-4672.
    • (2004) Antimicrob. Agents Chemother. , vol.48 , pp. 4665-4672
    • LaPlante, K.L.1    Rybak, M.J.2
  • 23
    • 0026047842 scopus 로고
    • Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis
    • Levine, D. P., B. S. Fromm, and B. R. Reddy. 1991. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680.
    • (1991) Ann. Intern. Med. , vol.115 , pp. 674-680
    • Levine, D.P.1    Fromm, B.S.2    Reddy, B.R.3
  • 24
    • 42049113605 scopus 로고    scopus 로고
    • Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
    • Lodise, T. P., B. Lomaestro, J. Graves, and G. L. Drusano. 2008. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob. Agents Chemother. 52: 1330-1336.
    • (2008) Antimicrob. Agents Chemother. , vol.52 , pp. 1330-1336
    • Lodise, T.P.1    Lomaestro, B.2    Graves, J.3    Drusano, G.L.4
  • 25
    • 67749147359 scopus 로고    scopus 로고
    • Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: Determination of epithelial lining fluid (ELF) targets
    • Louie, A., C. Fregeau, W. Liu, R. Kulawy, and G. L. Drusano. 2009. Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid (ELF) targets. Antimicrob. Agents Chemother. 53:3325-3330.
    • (2009) Antimicrob. Agents Chemother. , vol.53 , pp. 3325-3330
    • Louie, A.1    Fregeau, C.2    Liu, W.3    Kulawy, R.4    Drusano, G.L.5
  • 26
    • 2542482710 scopus 로고    scopus 로고
    • Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin
    • Meagher, A. K., A. Forrest, A. Dalhoff, H. Stass, and J. J. Schentag. 2004. Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin. Antimicrob. Agents Chemother. 48:2061-2068.
    • (2004) Antimicrob. Agents Chemother. , vol.48 , pp. 2061-2068
    • Meagher, A.K.1    Forrest, A.2    Dalhoff, A.3    Stass, H.4    Schentag, J.J.5
  • 27
    • 7444254040 scopus 로고    scopus 로고
    • Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
    • Moise-Broder, P. A., A. Forrest, M. C. Birmingham, and J. J. Schentag. 2004. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin. Pharmacokinet. 43:925-942.
    • (2004) Clin. Pharmacokinet. , vol.43 , pp. 925-942
    • Moise-Broder, P.A.1    Forrest, A.2    Birmingham, M.C.3    Schentag, J.J.4
  • 28
    • 2942515665 scopus 로고    scopus 로고
    • Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
    • Moise-Broder, P. A., G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering, Jr. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705.
    • (2004) Clin. Infect. Dis. , vol.38 , pp. 1700-1705
    • Moise-Broder, P.A.1    Sakoulas, G.2    Eliopoulos, G.M.3    Schentag, J.J.4    Forrest, A.5    Moellering Jr., R.C.6
  • 30
    • 62449183879 scopus 로고    scopus 로고
    • Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
    • Rybak, M., B. Lomaestro, J. C. Rotschafer, R. Moellering, Jr., W. Craig, M. Billeter, J. R. Dalovisio, and D. P. Levine. 2009. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am. J. Health Syst. Pharm. 66:82-98.
    • (2009) Am. J. Health Syst. Pharm. , vol.66 , pp. 82-98
    • Rybak, M.1    Lomaestro, B.2    Rotschafer, J.C.3    Moellering Jr., R.4    Craig, W.5    Billeter, M.6    Dalovisio, J.R.7    Levine, D.P.8
  • 33
    • 29244439618 scopus 로고    scopus 로고
    • Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy
    • Sakoulas, G., R. C. Moellering, Jr., and G. M. Eliopoulos. 2006. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin. Infect. Dis. 42(Suppl. 1):S40-S50.
    • (2006) Clin. Infect. Dis. , vol.42 , Issue.SUPPL. 1
    • Sakoulas, G.1    Moellering Jr., R.C.2    Eliopoulos, G.M.3
  • 34
    • 2942558870 scopus 로고    scopus 로고
    • Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
    • Sakoulas, G., P. A. Moise-Broder, J. Schentag, A. Forrest, R. C. Moellering, Jr., and G. M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42:2398-2402.
    • (2004) J. Clin. Microbiol. , vol.42 , pp. 2398-2402
    • Sakoulas, G.1    Moise-Broder, P.A.2    Schentag, J.3    Forrest, A.4    Moellering Jr., R.C.5    Eliopoulos, G.M.6
  • 36
    • 31944437335 scopus 로고    scopus 로고
    • Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus-type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus
    • DOI 10.1128/AAC.50.2.527-533.2006
    • Sieradzki, K., and A. Tomasz. 2006. Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus- type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus. Antimicrob. Agents Chemother. 50:527-533. (Pubitemid 43190962)
    • (2006) Antimicrobial Agents and Chemotherapy , vol.50 , Issue.2 , pp. 527-533
    • Sieradzki, K.1    Tomasz, A.2
  • 37
    • 29244453234 scopus 로고    scopus 로고
    • The role of vancomycin in the treatment paradigm
    • Stevens, D. L. 2006. The role of vancomycin in the treatment paradigm. Clin. Infect. Dis. 42(Suppl. 1):S51-S57.
    • (2006) Clin. Infect. Dis. , vol.42 , Issue.SUPPL. 1
    • Stevens, D.L.1
  • 38
    • 34249870835 scopus 로고    scopus 로고
    • Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial
    • Tam, V. H., A. Louie, T. R. Fritsche, M. Deziel, W. Liu, D. L. Brown, L. Deshpande, R. Leary, R. N. Jones, and G. L. Drusano. 2007. Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial. J. Infect. Dis. 195:1818-1827.
    • (2007) J. Infect. Dis. , vol.195 , pp. 1818-1827
    • Tam, V.H.1    Louie, A.2    Fritsche, T.R.3    Deziel, M.4    Liu, W.5    Brown, D.L.6    Deshpande, L.7    Leary, R.8    Jones, R.N.9    Drusano, G.L.10
  • 39
    • 33846915413 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains
    • Treyaprasert, W., S. Schmidt, K. H. Rand, U. Suvanakoot, and H. Derendorf. 2007. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains. Int. J. Antimicrob. Agents 29:263-270.
    • (2007) Int. J. Antimicrob. Agents , vol.29 , pp. 263-270
    • Treyaprasert, W.1    Schmidt, S.2    Rand, K.H.3    Suvanakoot, U.4    Derendorf, H.5
  • 40
    • 21444454242 scopus 로고    scopus 로고
    • Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
    • Tsuji, B. T., and M. J. Rybak. 2005. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 49:2735-2745.
    • (2005) Antimicrob. Agents Chemother. , vol.49 , pp. 2735-2745
    • Tsuji, B.T.1    Rybak, M.J.2
  • 41
    • 33847627949 scopus 로고    scopus 로고
    • Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus
    • Tsuji, B. T., M. J. Rybak, K. L. Lau, and G. Sakoulas. 2007. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51:1089-1091.
    • (2007) Antimicrob. Agents Chemother. , vol.51 , pp. 1089-1091
    • Tsuji, B.T.1    Rybak, M.J.2    Lau, K.L.3    Sakoulas, G.4
  • 42
    • 42049122118 scopus 로고    scopus 로고
    • Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype
    • Tsuji, B. T., C. von Eiff, P. A. Kelchlin, A. Forrest, and P. F. Smith. 2008. Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype. Antimicrob. Agents Chemother. 52:1533-1537.
    • (2008) Antimicrob. Agents Chemother. , vol.52 , pp. 1533-1537
    • Tsuji, B.T.1    Von Eiff, C.2    Kelchlin, P.A.3    Forrest, A.4    Smith, P.F.5
  • 43
    • 0033697445 scopus 로고    scopus 로고
    • Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus
    • Vuong, C., H. L. Saenz, F. Gotz, and M. Otto. 2000. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J. Infect. Dis. 182:1688-1693.
    • (2000) J. Infect. Dis. , vol.182 , pp. 1688-1693
    • Vuong, C.1    Saenz, H.L.2    Gotz, F.3    Otto, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.